Last update:

Vaccination news

Health

Flu activity is low, but experts worry about a new strain and vaccination rates

The U.S. flu season is starting slowly, and it's unclear if it will be as bad as last winter's, but some health experts are worried as U.S. Centers for Disease Control and Prevention data posted Friday shows a new version ...

Vaccination

Experimental vaccine offers rapid, long-lasting protection against deadly tick-borne virus

Crimean-Congo hemorrhagic fever (CCHF) is one of the world's most dangerous yet overlooked infectious diseases. Spread by ticks and livestock, the virus causes sudden fever, organ failure, and internal bleeding, killing up ...

Diseases, Conditions, Syndromes

HHS proposes new CDC programs, including hepatitis B screening

The Health and Human Services Department is proposing new initiatives for the Centers for Disease Control and Prevention, including a program to increase hepatitis B screening for pregnant women, as part of a broader push ...

Autism spectrum disorders

Vaccines 'don't cause autism': How scientists figured that out

In the late 1990s, a theory gripped parents around the world: What if childhood vaccines—particularly the combined measles-mumps-rubella vaccine—cause autism? Nearly three decades later, the debunked theory has gained ...

Immunology

Common cold virus may unlock better COVID vaccine

Prior exposure to coronaviruses that cause ordinary colds can boost the immune system's ability to attack a vulnerable site on the COVID-19-causing coronavirus SARS-CoV-2, according to a study led by investigators at Weill ...

Vaccination

Randomized trials show no evidence of non-specific vaccine effects

For more than three decades, researchers Christine Stabell Benn and Peter Aaby from the Bandim Health Project have conducted randomized trials involving thousands of children in Guinea-Bissau and Denmark to demonstrate so-called ...

Immunology

Flu vaccine performance varies by age, study reveals

New research comparing four different flu vaccines found that the ability of the vaccines to activate cells of the immune system that help to protect against infection varied greatly depending on the vaccine type and age ...

Oncology & Cancer

Nasal therapeutic HPV vaccine could prevent cervical cancer

Cervical cancer, which affects the reproductive tract, is one of the most common cancers in women worldwide. It is primarily caused by human papillomavirus (HPV), a viral infection that spreads through sexual contact.

Diseases, Conditions, Syndromes

Texas whooping cough cases reach record high, data shows

Pertussis, also known as whooping cough, has reached a record high, with over 3,500 cases reported in Texas to date, according to a Texas Department of State Health Services health alert.

Vaccination

No-needle test can tell if flu/COVID vaccines are effective

A team of researchers at the University of Pittsburgh has developed a skin patch that can detect antibodies associated with COVID and flu infections. It's orders of magnitude more sensitive than existing tests, uses just ...

Oncology & Cancer

Nanovaccine shows great promise for treating HPV-related cancers

A nanoparticle vaccine designed to fight cancers induced by human papillomavirus (HPV) eradicated tumors in an animal model of late-stage metastatic disease, UT Southwestern Medical Center scientists report in a new study ...

Diseases, Conditions, Syndromes

Canada loses measles elimination status after ongoing outbreaks

Canada is no longer measles-free because of ongoing outbreaks, international health experts said Monday, as childhood vaccination rates fall and the highly contagious virus spreads across North and South America.

Diseases, Conditions, Syndromes

At least 15 whooping cough cases confirmed in Kansas

Whooping cough cases are on the rise in Wyandotte County, Kansas, and local health officials are advising residents to keep an eye out for symptoms of the illness and stay up to date with their vaccinations.

Oncology & Cancer

Dual-action mRNA vaccine takes aim at aggressive skin cancer

Yale researchers have developed a new vaccine that does double duty against a rare and aggressive skin cancer by targeting the protein essential to tumor cell growth and by adding a key signal to boost the immune system response. ...